NEWS BEI OXFORD VENTURES!!! - 500 Beiträge pro Seite
eröffnet am 01.11.05 18:36:29 von
neuester Beitrag 01.11.05 22:59:52 von
neuester Beitrag 01.11.05 22:59:52 von
Beiträge: 21
ID: 1.016.955
ID: 1.016.955
Aufrufe heute: 0
Gesamt: 857
Gesamt: 857
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 55 Minuten | 7888 | |
| vor 46 Minuten | 5021 | |
| heute 14:19 | 2630 | |
| vor 1 Stunde | 2620 | |
| vor 1 Stunde | 2348 | |
| vor 51 Minuten | 2089 | |
| vor 1 Stunde | 2040 | |
| vor 1 Stunde | 1787 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 17.875,43 | -1,18 | 239 | |||
| 2. | 3. | 163,39 | +0,78 | 94 | |||
| 3. | 2. | 9,2700 | -3,89 | 90 | |||
| 4. | 4. | 0,1915 | -1,29 | 84 | |||
| 5. | 6. | 0,0330 | +56,40 | 52 | |||
| 6. | 14. | 6,9600 | +3,29 | 51 | |||
| 7. | 34. | 0,6600 | -52,86 | 49 | |||
| 8. | 13. | 437,52 | -11,34 | 47 |
Feedback
NEWS!!
USA BEREITS +40%
OXFORD VENTURES INC Quick Quote: OXFV 0.00 (-0.00)
ULURU Awarded a U.S. Army Small Business Innovative Research Grant; Grant to Support the Development of a Wound Dressing for Burns
11/1/05
DALLAS, Nov 01, 2005 (BUSINESS WIRE) --
ULURU INC. ("ULURU") who has signed a definitive merger agreement with Oxford Ventures, Inc. (OTC Bulletin Board: OXFV) today announced the award of a U.S. Army Small Business Innovative Research ("SBIR") Grant.
The U.S. Army SBIR Program has competitively selected a proposal that utilizes ULURU`s Hydrogel Nanoparticle Aggregate Technology for award and contract negotiation. The objective of the SBIR proposal solicitation, topic number A05-131, was to design and manufacture a wound dressing that can be placed over burns to enhance the rate of wound closure. Such a dressing should be capable of absorbing wound fluids, speed up the rate of wound healing, require few dressing changes (e.g. can be left in place for up to seven days), provide antibacterial action, deliver nutritive substances, have a long shelf life (e.g. one year) and not require special storage conditions (e.g. freezing).
We believe that ULURU`s Hydrogel Nanoparticle Aggregate Technology is well suited for wound healing as it is designed to modify the biochemical environment of a wound in order to maintain an optimum moisture balance with concomitant drug release and has the necessary properties to achieve the design features outlined in the U.S. Army SBIR proposal. Utilizing our innovative Hydrogel Nanoparticle Aggregate topical delivery technology for development of an advanced burn care product outlined in this SBIR is a primary focus of our burn care and wound management product portfolio. ULURU is striving to develop in vitro and in vivo proof-of-concept experiments as specified in the Phase I objectives of the SBIR proposal. To date, we are showing promising results for the improved treatment of burns.
ULURU is applying for up to a $1 million fast-track Phase II SBIR funding to develop and demonstrate the efficacy of a prototype wound dressing and move into human clinical trials. By improving treatment to return damaged skin to optimal appearance and normal function in the shortest time, we anticipate that this wound dressing could be used in a broad range of military and civilian medical settings and may benefit many military and civilian patients suffering from chronic vesicant injuries.
Commenting on the SBIR award Kerry P. Gray, President and CEO of ULURU stated, "This is an important scientific validation of our Hydrogel Nanoparticle Aggregate Technology for the development of burn and wound management products. We look forward to working with the Army to optimize a burn care product for military use."
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of topical delivery technologies to provide patients and consumers with an improved clinical outcome through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate Technology.
SOURCE: ULURU Inc.
ULURU Inc. Kerry P. Gray, 214-905-5145
Copyright Business Wire 2005
USA BEREITS +40%
OXFORD VENTURES INC Quick Quote: OXFV 0.00 (-0.00)
ULURU Awarded a U.S. Army Small Business Innovative Research Grant; Grant to Support the Development of a Wound Dressing for Burns
11/1/05
DALLAS, Nov 01, 2005 (BUSINESS WIRE) --
ULURU INC. ("ULURU") who has signed a definitive merger agreement with Oxford Ventures, Inc. (OTC Bulletin Board: OXFV) today announced the award of a U.S. Army Small Business Innovative Research ("SBIR") Grant.
The U.S. Army SBIR Program has competitively selected a proposal that utilizes ULURU`s Hydrogel Nanoparticle Aggregate Technology for award and contract negotiation. The objective of the SBIR proposal solicitation, topic number A05-131, was to design and manufacture a wound dressing that can be placed over burns to enhance the rate of wound closure. Such a dressing should be capable of absorbing wound fluids, speed up the rate of wound healing, require few dressing changes (e.g. can be left in place for up to seven days), provide antibacterial action, deliver nutritive substances, have a long shelf life (e.g. one year) and not require special storage conditions (e.g. freezing).
We believe that ULURU`s Hydrogel Nanoparticle Aggregate Technology is well suited for wound healing as it is designed to modify the biochemical environment of a wound in order to maintain an optimum moisture balance with concomitant drug release and has the necessary properties to achieve the design features outlined in the U.S. Army SBIR proposal. Utilizing our innovative Hydrogel Nanoparticle Aggregate topical delivery technology for development of an advanced burn care product outlined in this SBIR is a primary focus of our burn care and wound management product portfolio. ULURU is striving to develop in vitro and in vivo proof-of-concept experiments as specified in the Phase I objectives of the SBIR proposal. To date, we are showing promising results for the improved treatment of burns.
ULURU is applying for up to a $1 million fast-track Phase II SBIR funding to develop and demonstrate the efficacy of a prototype wound dressing and move into human clinical trials. By improving treatment to return damaged skin to optimal appearance and normal function in the shortest time, we anticipate that this wound dressing could be used in a broad range of military and civilian medical settings and may benefit many military and civilian patients suffering from chronic vesicant injuries.
Commenting on the SBIR award Kerry P. Gray, President and CEO of ULURU stated, "This is an important scientific validation of our Hydrogel Nanoparticle Aggregate Technology for the development of burn and wound management products. We look forward to working with the Army to optimize a burn care product for military use."
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of topical delivery technologies to provide patients and consumers with an improved clinical outcome through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate Technology.
SOURCE: ULURU Inc.
ULURU Inc. Kerry P. Gray, 214-905-5145
Copyright Business Wire 2005
Jetzt aber schnell noch rein bevor morgen die 0,007 fallen
...das wird noch n spasss...
...der cent rückt wieder näher....
...der cent rückt wieder näher....
Wenn Uluru wirklich mit der U.S.Army ins Geschäft kommt, dann sind Oxford-Aktionäre gemachte Leute
So long KingKong
So long KingKong
aktuell:
0,0063
umsatz 28 mio
über 40 %
0,0063
umsatz 28 mio
über 40 %
Trading Spotlight
...sorry 18 mio...
Berlin zieht nach....
ISIN US6918231084
So long KingKong
ISIN US6918231084
So long KingKong
so, da bin ich auch wieder... war kurz essen...
0.0058 + +0.0014 +31.82% N/A N/A 0.0057 0.006 +
0.0058 + +0.0014 +31.82% N/A N/A 0.0057 0.006 +
das ist immer gut! gleich wachen die ammis richtig auf!
http://www.stockhouse.com/news/news.asp?tick=OXFV&newsid=298…
http://www.stockhouse.com/news/news.asp?tick=OXFV&newsid=298…
ja !!!
OXFV.OB 1:21pm 0.006 + +0.0016 +36.36% N/A N/A 0.0059 + 0.006
OXFV.OB 1:21pm 0.006 + +0.0016 +36.36% N/A N/A 0.0059 + 0.006
in berlin ist unter 0,006 auch alles abgeräumt... das wird nach 20 uhr noch was geben... 
consolidation between .0056/.0062
very nice intraday chart...no worry here...this is still very bullish
very nice intraday chart...no worry here...this is still very bullish
...ich hoffe übrigens, daß sie den namen jetzt mal ne weile behalten :
....
The company was formed in 1987 under the name Casinos of the World, Inc. and changed its name to Clean Way Corporation in 1993. The name was further changed to Trader Secrets.com, Inc. in 1999; to VOIP Technology, Inc. in 2000; and then to Oxford Ventures, Inc. in 2002. Oxford Ventures is based in Omaha, Nebraska.
....
:....
The company was formed in 1987 under the name Casinos of the World, Inc. and changed its name to Clean Way Corporation in 1993. The name was further changed to Trader Secrets.com, Inc. in 1999; to VOIP Technology, Inc. in 2000; and then to Oxford Ventures, Inc. in 2002. Oxford Ventures is based in Omaha, Nebraska.
....
Schaut mal da:
http://www.wallstreet-online.de/si/community/board/threadpag…
im Posting #1 gibts noch ein paar Info´s
http://www.wallstreet-online.de/si/community/board/threadpag…
im Posting #1 gibts noch ein paar Info´s
gleich gehts weiter... ist doch immer das selbe... sobald in berlin das licht aus ist gehts richtig los... freue mich schon auf die schlussrally in amerika...
ROCK N ROLL
die news ist ein kracher
die news ist ein kracher
so leute, bin weg (bis zur schlussrally :laugh.... muss kurz zum birthday...
.... muss kurz zum birthday...
tjaa, wer hätte das gedacht...
...nur noch 2 % im plus
...nur noch 2 % im plus
ohh...wieder 15 %
...n dolles teil is das
...n dolles teil is das
+18 % ist doch ne super sache..............ganz gemächlich gen norden........
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 228 | ||
| 96 | ||
| 90 | ||
| 76 | ||
| 53 | ||
| 49 | ||
| 48 | ||
| 44 | ||
| 42 | ||
| 33 |
| Wertpapier | Beiträge | |
|---|---|---|
| 28 | ||
| 27 | ||
| 27 | ||
| 26 | ||
| 26 | ||
| 24 | ||
| 23 | ||
| 22 | ||
| 21 | ||
| 21 |
